A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: All participants: * Is a continuous non-smoker or moderate smoker (≤ 10 cigarettes per day or equivalent) for at least 3 months prior to dosing * Has body mass index (BMI) ≥ 18.0 and ≤ 40.0 kg/m\^2 Participants with Mild HI (Group 1) and Moderate HI (Group 2): * Has mild or moderate hepatic impairment * Has a diagnosis of chronic, stable, hepatic insufficiency with features of cirrhosis due to any etiology * Is generally in good health with the exception of HI Healthy Control Participants (Group 3): \- Healthy with no clinically significant medical history, physical examination, clinical laboratory profiles, vital signs, and ECGs Exclusion Criteria: The main exclusion criteria include but are not limited to the following: All participants: * Has a history of cancer (malignancy) * Has positive results for human immunodeficiency virus (HIV) * Has had major surgery and/or donated or lost significant volume of blood within 56 days prior to dosing Participants with Mild HI (Group 1) and Moderate HI (Group 2): * With the exception of HI, has a history or presence of clinically significant medical or psychiatric condition or disease * Is positive for Hepatitis B surface antigen (HBsAg) or Hepatitis B core antibody (HBcAb) * Is positive for Hepatitis C Virus (HCV)